Skip to content

Venture

LOGO 11-01

Affiliations

New York University

Technologies

Diagnostic

Digital Health Technology

Indication

Central Nervous System Disorders

Clinical Research

Drug Discovery

Musculoskeletal Disorders

Oncology

We are a service company that improves medical image quality via advanced post-processing and uses this improvement to develop quantitive biomarkers specific to cellular-level pathology.

Team:

Lieven Nuyttens, CEO
Gregory Lemberskiy, CTO